Technology Transfer of Dementia Treatment Herbal Medicine 'Biopharma'

[Asia Economy Reporter Junho Hwang] The Korea Institute of Oriental Medicine announced that the research team led by Dr. Jeon Won-gyeong of the Herbal Medicine Research Department, participating in the Dementia DTC Convergence Research Group under the National Science and Technology Research Council, has transferred the technology for the "Development of Herbal Medicine-Based Compositions for Dementia Treatment" to Biopharma Co., Ltd.

The technology transfer and joint research agreement ceremony was held on the 18th at the Korea Institute of Science and Technology (President Seokjin Yoon), the host institution of the Dementia DTC Convergence Research Group, in the Industry-Academic Cooperation Research Building. The technology transfer was concluded under the conditions of an upfront payment of 500 million KRW and a running royalty of 1.5% of total sales.

The transferred composition is a therapeutic substance derived from materials known as both herbal medicines and food ingredients. Through animal experiments, the research team demonstrated the efficacy and mechanism of action of the substance in normalizing cognitive impairment caused by dementia. Safety was also confirmed through toxicity testing. All research results were published in the international journal Nutrients.

Dr. Jeon Won-gyeong of the Herbal Medicine Research Department stated, "This technology transfer has accelerated the commercialization of herbal medicine-based compositions for dementia treatment," adding, "We will continue follow-up research to treat dementia patients."

This content was produced with the assistance of AI translation services.